Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Östör · SciRah

Researcher profile · Semantic Scholar

A. Östör

Share profile

A. Östör — researcher profile on SciRah

h-index: 27
Works: 121
Citations: 4,506

Most-cited papers

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
J. Smolen, F. Breedveld, G. Burmester, V. Bykerk +39 more
2015Annals of the Rheumatic Diseases1,425 citations Open access
Semantic Scholar
Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials.
L. Campbell, Cheng Chen, S. Bhagat, R. Parker +1 more
2011Rheumatology279 citations Open access
Semantic Scholar
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study
P. Emery, J. Gottenberg, A. Rubbert-Roth, P. Sarzi-Puttini +11 more
2014Annals of the Rheumatic Diseases154 citations Open access
Semantic Scholar
Anti-Tumor Necrosis Factor-&agr; Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis
K. Maki-Petaja, M. Elkhawad, J. Cheriyan, F. Joshi +4 more
2012Circulation151 citations Open access
Semantic Scholar
A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases
E. Vangeli, Savita Bakhshi, A. Baker, A. Fisher +6 more
2015Advances in Therapy146 citations Open access
Semantic Scholar
Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review
T. Gout, A. Östör, M. Nisar
2011Clinical Rheumatology139 citations
Semantic Scholar
Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice
V. Bykerk, A. Östör, J. Álvaro-Gracia, K. Pavelka +8 more
2012Annals of the Rheumatic Diseases107 citations Open access
Semantic Scholar
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial
A. Östör, F. E. Van den Bosch, K. Papp, C. Asnal +9 more
2021Annals of the Rheumatic Diseases98 citations Open access
Semantic Scholar
Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort
E. Nikiphorou, A. Negoescu, J. Fitzpatrick, C. Goudie +3 more
2014Clinical Rheumatology93 citations
Semantic Scholar
Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series.
E. Mitchell, Peter K. H. Lau, C. Khoo, D. Liew +23 more
2018European Journal of Cancer67 citations
Semantic Scholar
Interleukin-6 and cytochrome-P450, reason for concern?
S. Kim, A. Östör, M. Nisar
2012Rheumatology International62 citations
Semantic Scholar
Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension
D. M. van der Heijde, A. Deodhar, W. Maksymowych, J. Sieper +9 more
2022RMD Open43 citations Open access
Semantic Scholar
Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region
Z. Kaló, Z. Vokó, A. Östör, E. Clifton-Brown +3 more
2017Journal of Market Access & Health Policy40 citations Open access
Semantic Scholar
Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice
V. Bykerk, A. Östör, J. Álvaro-Gracia, K. Pavelka +8 more
2015Clinical Rheumatology39 citations Open access
Semantic Scholar
Does methotrexate increase the risk of varicella or herpes zoster infection in patients with rheumatoid arthritis? A systematic literature review.
Natalie Zhang, S. Wilkinson, Mehmood Riaz, A. Östör +1 more
2012Clinical and Experimental Rheumatology38 citations
Semantic Scholar
Pulmonary adverse events of small molecule JAK inhibitors in autoimmune disease: systematic review and meta-analysis.
J. Khoo, H. Barnes, S. Key, I. Glaspole +1 more
2020Rheumatology37 citations
Semantic Scholar
What do we know about juvenile idiopathic arthritis and vitamin D? A systematic literature review and meta-analysis of current evidence
M. Nisar, F. Masood, P. Cookson, A. Sansome +1 more
2013Clinical Rheumatology33 citations
Semantic Scholar
Tetrahydrobiopterin Supplementation Improves Endothelial Function But Does Not Alter Aortic Stiffness in Patients With Rheumatoid Arthritis
K. Maki-Petaja, L. Day, J. Cheriyan, F. Hall +3 more
2016Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease32 citations Open access
Semantic Scholar
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study
A. Östör, F. E. Van den Bosch, K. Papp, C. Asnal +8 more
2022Rheumatology31 citations Open access
Semantic Scholar
Rheumatoid arthritis and the era of biologic therapy
A. Malaviya, A. Östör
2012InflammoPharmacology28 citations
Semantic Scholar
Biologic agents for rheumatoid arthritis—negotiating the NICE technology appraisals
P. Kiely, C. Deighton, J. Dixey, A. Östör
2011Rheumatology28 citations Open access
Semantic Scholar
Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom
M. Nisar, Aneesa Rafiq, A. Östör
2015Clinical Rheumatology26 citations
Semantic Scholar
Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies
Faye A. H. Cooles, A. Anderson, T. Drayton, R. Harry +5 more
2016Arthritis Research & Therapy25 citations Open access
Semantic Scholar
Validation of clinical examination versus magnetic resonance imaging and arthroscopy for the detection of rotator cuff lesions
A. Östör, C. Richards, G. Tytherleigh-Strong, Philip W. Bearcroft +3 more
2013Clinical Rheumatology25 citations
Semantic Scholar
Anti-Tumor Necrosis Factor- (cid:1) Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis
K. Maki-Petaja, M. Elkhawad, J. Cheriyan, F. Joshi +4 more
201223 citations
Semantic Scholar
Drug adherence to biologic DMARDS with a special emphasis on the benefits of subcutaneous abatacept
A. Malaviya, A. Östör
2012Patient Preference and Adherence23 citations Open access
Semantic Scholar
Quantifying disease activity in rheumatoid arthritis with the TSPO PET ligand 18F-GE-180 and comparison with 18F-FDG and DCE-MRI
M. de Groot, Neel Patel, R. Manavaki, R. Janiczek +12 more
2019EJNMMI Research20 citations Open access
Semantic Scholar
Tapering versus steady-state methotrexate in combination with tocilizumab for rheumatoid arthritis: a randomized, double-blind trial
C. Edwards, A. Östör, B. Naisbett-Groet, P. Kiely
2018Rheumatology20 citations Open access
Semantic Scholar
Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis
V. Navarro-Compán, X. Baraliakos, M. Magrey, A. Östör +6 more
2023Rheumatology and Therapy15 citations Open access
Semantic Scholar
Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients
R. Alten, G. Burmester, M. Matucci-Cerinic, Jean-Hugues Salmon +6 more
2023Rheumatology and Therapy14 citations Open access
Semantic Scholar
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial
A. Östör, F. E. Van den Bosch, K. Papp, C. Asnal +10 more
2024Rheumatology and Therapy12 citations Open access
Semantic Scholar
Evaluating the patient with low back pain.
M. Shaikh, A. Östör
2015Practitioner10 citations
Semantic Scholar
Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice
V. Bykerk, A. Östör, J. Álvaro-Gracia, K. Pavelka +6 more
2019Clinical Rheumatology9 citations Open access
Semantic Scholar
Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the ‘age of remission’?
R. Moots, A. Östör, J. Isaacs
2009Expert Opinion on Investigational Drugs9 citations Open access
Semantic Scholar
The prevalence and impact of polypharmacy in rheumatology.
J. Lewis, A. Östör
2023Rheumatology8 citations
Semantic Scholar
Barriers to, Facilitators of, and Interventions to Support Treat‐to‐Target Implementation in Rheumatoid Arthritis: A Systematic Review
L. Gossec, L. Bessette, R. Xavier, E. Favalli +2 more
2024Arthritis care & research7 citations Open access
Semantic Scholar
26. Refractory Rheumatoid Arthritis with Interstitial Lung Disease: Could Abatacept Be the Answer?
F. Hayes, A. Östör
20146 citations
Semantic Scholar
AB0364 Abatacept and its Impact on Interstitial Lung Disease: A Systematic Literature Review
D. Nelson, M. Mclaughlin, A. Östör
20155 citations
Semantic Scholar
Topical NSAIDS provide effective pain relief for patients with hand or knee osteoarthritis with similar efficacy, and fewer side effects, than oral NSAIDS
A. Östör, P. Watson
2012Evidence-Based Medicine5 citations
Semantic Scholar
Update on biosimilars in rheumatology
A. Rischin, A. Östör
2017InflammoPharmacology4 citations
Semantic Scholar
The effect of risankizumab on achieving minimal clinically important differences in patient‐reported outcomes in patients with psoriatic arthritis: results from KEEPsAKE 1 and 2
LE Kristensen, A. Soliman, K. Papp, L. Barcomb +2 more
2022Journal of the European Academy of Dermatology and Venereology3 citations Open access
Semantic Scholar
Refining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous Tocilizumab
A. Negoescu, A. Östör
2014Rheumatology and Therapy3 citations Open access
Semantic Scholar
The role of tocilizumab monotherapy in the management of rheumatoid arthritis: a review
M. Nisar, A. Östör
20123 citations
Semantic Scholar
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-Week Results from the KEEPsAKE 1 and KEEPsAKE 2 Randomized Clinical Trials
A. Östör, F. E. Van den Bosch, K. Papp, M. Keiserman +12 more
2025Rheumatology and Therapy2 citations Open access
Semantic Scholar
Refractory Rheumatoid Arthritis and Associated Interstitial Lung Disease: Could Abatacept be the Answer?
W. Ye, M. Fifield, A. Östör
2017Journal of clinical rheumatology2 citations
Semantic Scholar
AB0693 Is there a link between vitamin d and juvenile idiopathic arthritis?
M. Nisar, P. Cookson, F. Masood, A. Sansome +1 more
20132 citations
Semantic Scholar
Anti-cytokine biologics
A. Östör
20132 citations
Semantic Scholar
THU0135 “indispensable or intolerable?” a retrospective review of methotrexate discontinuation in rheumatoid arthritis
A. J. Badcock, A. Malaviya, A. Östör
20132 citations
Semantic Scholar
FRI0200 Relative effectiveness of rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis and an inadequate response to a single previous TNF inhibitor: Results from switch-RA, a global, comparative-effectiveness, observational study
P. Emery, J. Gottenberg, P. Sarzi-Puttini, R. Moots +9 more
20132 citations
Semantic Scholar
FRI0179 Comparison of tocilizumab as monotherapy or in combination with non-biological disease-modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA) and an inadequate response to anti-TNF agents
A. Östör, J. R. Román Ivorra, J. Wollenhaupt, C. Mpofu +3 more
20132 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Nisar×7
Invite
M. Nisar — researcher profile on SciRah
V. Bykerk×5
Invite
V. Bykerk — researcher profile on SciRah
F. E. Van den Bosch×5
Invite
F. E. Van den Bosch — researcher profile on SciRah
K. Papp×5
Invite
K. Papp — researcher profile on SciRah

×4

Invite

J. Sibilia — researcher profile on SciRah

Invite

A. Kivitz — researcher profile on SciRah

Invite

A. Malaviya — researcher profile on SciRah

W. Graninger×3

Invite

W. Graninger — researcher profile on SciRah

Invite

R. Moots — researcher profile on SciRah

Invite

C. Mpofu — researcher profile on SciRah

K. Maki-Petaja×3

Invite

K. Maki-Petaja — researcher profile on SciRah

Invite

J. Cheriyan — researcher profile on SciRah